PM urges EC and EMA to approve Johnson&Johnson vaccine
The prime minister has urged the European Commission and the European Medicines Agency to approve the Johnson&Johnson vaccine as soon as possible.
Mateusz Morawiecki wrote on Facebook and Twitter on Thursday that the effects of vaccination are visible, with the number of infections in vaccinated medics 20 times lower.
"On such a special day like this, with exactly one year passing since the first case of Covid-19 was discovered in Poland, we need such information,” he wrote. “The dedication and hard work of millions of people in Poland and around the world, from scientists, doctors, to drugs suppliers and nurses administering doses of the vaccine bring tangible results."
He added that “there is only one conclusion, the process must be accelerated and the citizens of Poland the EU protected.”
“No time to waste. Every day counts,” he stressed.
The European Medicines Agency (EMA) has already approved the use of three COVID-19 vaccines: the AstraZeneca/Oxford, BioNtech/Pfizer and Moderna. Three more vaccines are being assessed: the American Novavax, Johnson&Johnson and the German Curevax.